Skip to content

The value assessment of bedside ultrasound combined with plasma D-dimer in the diagnosis of DVT in ICU patients

The value assessment of bedside ultrasound combined with plasma D-dimer in the diagnosis of DVT in ICU patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123726
Enrollment
Unknown
Registered
2026-04-29
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis

Interventions

Gold Standard:In this study, bedside color Doppler ultrasound combined with comprehensive clinical assessment (including underlying diseases, DVT risk factors, clinical signs and symptoms, dynamic lab
Index test:bedside ultrasound machine (Mindray M9, color Doppler mode) and plasma D-dimer analyzer (Mindray automated coagulation analyzer CX-9000)

Sponsors

Meishan City Peoples Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. ICU length of stay = 48 hours (to ensure exposure to ICU-related DVT risk factors); 2. Presence of at least one high-risk factor for DVT (including advanced age =65 years, history of surgery within the past 3 months, mechanical ventilation duration =24 hours, central venous catheterization, malignancy, obesity, etc. [1]); 3. Completion of plasma D-dimer testing and bedside lower extremity venous ultrasound examination within 48 hours of admission; 4. Complete clinical data (including underlying diseases, diagnostic and therapeutic procedures, test results, and follow-up outcomes).

Exclusion criteria

Exclusion criteria: 1. History of lower extremity DVT or pulmonary embolism (which may affect the interpretation of test results); 2. Received anticoagulant therapy (e.g., low molecular weight heparin, warfarin) before ICU admission; 3. Concomitant severe liver or kidney failure (Child-Pugh Class C liver function or serum creatinine >442 µmol/L, which may interfere with D-dimer metabolism); 4. Incomplete ultrasound examination with assessment of only proximal or distal sites; 5. Missing clinical follow-up data, precluding comprehensive evaluation.

Design outcomes

Primary

MeasureTime frame
sensitivity;specificity;positive predictive value;Negative Predictive Value;

Countries

China

Contacts

Public ContactZhang Sha

Meishan City Peoples Hospital

ahsgnahz@163.com+86 28 3822 3102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026